Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 365

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 365
---
 certified nutrigenetic specialists, which we plan to scale through the use of AI Agents, which are designed to support users in adopting lifestyle changes based on genetic and microbiome insights.; and •Heritas Diagnostics: a suite of clinical genetic testing services focused on reproductive health, oncology, rare diseases, and clinical gut health. Our tests integrate genetic and clinical data to provide precise and actionable insights that support accurate diagnoses, effective monitoring and informed treatment decisions. We ensure that our comprehensive clinical reports deliver the necessary insights needed by both patients and physicians to interpret results and make informed treatment decisions. To enhance accessibility and support, we plan to incorporate AI Agents, expected to have its first commercial use as early as 2026, that will assist patients in interpreting their results and providing personalized treatment recommendations, complementing physician guidance. Rewell: Wellness and Prevention We believe that Rewell will be at the forefront of wellness and prevention, enabling consumers to obtain personalized genetics and gut microbiome information, with nutrition recommendations and habit plans that support informed life changes that would mitigate disease initiation and development and improve overall wellbeing. Rewell’s proprietary platform provides personalized DNA and microbiome results by integrating customer’s genetic and lifestyle data and associated risk factors and comparing these results to both a standard and proprietary database. This aims at lowering the chances of developing low grade chronic inflammation over time, as Rewell provides insights from personal genomic information and their impact on and long -termhabits. According to the research paper titled “Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort”, published in Nature Genetics on February 3, 2022, diets and environmental factors have a greater influence on the human gut microbiome than host genetics. Given these results, to provide accurate and relevant insights that account for geographical influences, we based the gut microbiome results provided by Rewell on a proprietary database constructed through patient trials tailored to the geography where the services are offered. This reference database was constructed through a citizen science initiative conducted from December 2015 through December 2016, which recruited 200 volunteers with healthy habits as a reference data database for human gut microbiome analysis. These volunteers were from various rural and urban areas in Argentina, who were recruited, compiled, and analyzed by Heritas Argentina and CIBIC as an open citizen science project. Volunteers were instructed about the project and directed to four partner clinical labs in the different cities participating in the project for sample collection and signing an informed consent. In the screening phase, individuals who did not meet